Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
—
—
—
Shree Ganesh Remedies Limited is engaged in manufacturing and dispatching of drug intermediates and chemicals for pharmaceutical industry. The Company manufactures products relating to antipsychotic, antiseptic, deprotonation reactions etc.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
Shree Ganesh Remedies Ltd - 540737 - Disclosure Under Regulation 29 (2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011. | Download
Shree Ganesh Remedies Ltd - 540737 - Disclosure Under Regulation 29 (2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011. | Download
Shree Ganesh Remedies Ltd - 540737 - Disclosure Under Regulation 29 (2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011. | Download
Shree Ganesh Remedies Ltd - 540737 - Disclosure Under Regulation 29 (2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011. | Download
Final • Div/Share: ₹ 0.5
Increased Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has increased by 1.16%